NLS Pharmaceutics

-$0.0149 (-2.33%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLSP and other ETFs, options, and stocks.

About NLSP

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness (EDS) and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder (ADHD).

CEO
Alexander Zwyer
Employees
6
Headquarters
Zurich, Zurich
Founded
2015

NLSP Key Statistics

Market cap
12.02M
Price-Earnings ratio
—
Dividend yield
—
Average volume
78.74K
High today
$0.67
Low today
$0.582
Open price
$0.62
Volume
107.91K
52 Week high
$3.73
52 Week low
$0.55

NLSP Earnings

Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Feb 25, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure